B Cell-Activating Factor Of The Tnf Family Expands Circulating Transitional B Cells In Multiple Sclerosis Patients Treated With Fingolimod
JOURNAL OF THE NEUROLOGICAL SCIENCES(2017)
Abstract
Background: Fingolimod is a sphingosine-1-phosphate receptor agonist used as a disease-modifying drug for multiple sclerosis (MS). We have previously shown that MS patients treated with fingolimod have an increased proportion of circulating transitional B cells, an immunoregulatory B-cell subset, but the underlying mechanism remains unknown. B cell-activating factor of the TNF family (BAFF) is a cytokine involved in the differentiation and proliferation of B cells. Mice overexpressing BAFF have been shown to have increased numbers of transitional B cells.
MoreTranslated text
Key words
multiple sclerosis,multiple sclerosis patients,tnf family,cell-activating
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined